BioTelemetry (BEAT) To Report Q1 Earnings: What's In Store?
Zacks Investment Research | Apr 23, 2019 08:49AM ET
BioTelemetry, Inc. (NASDAQ:BEAT) is set to report first-quarter 2019 results on Apr 25, after market close. The company expects to gain from core Healthcare Services business in the quarter to be reported.
In the last reported quarter, the company delivered a positive earnings surprise of 33.3%. Further, it has an average four-quarter positive surprise of 50.8%.
Which Way Are Estimates Heading?
For the quarter to be reported, the Zacks Consensus Estimate for earnings stands at 43 cents, suggesting year-over-year growth of 10.3%. The same for revenues stands at $104.3 million, indicating an increase of 10.4% year over year.
BioTelemetry, Inc. Price and EPS Surprise
.
BioTelemetry has a Zacks Rank #1 and an Earnings ESP of 0.00%, a combination that does not suggest an earnings beat in the quarter to be reported.
Stocks Worth a Look
Here are a few medical stocks worth considering as they have the right combination of elements to post a beat this earnings season:
Cardinal Health (NYSE:CAH) , with an Earnings ESP of +1.13% and a Zacks Rank #3.
Stryker Corporation (NYSE:SYK) , with an Earnings ESP of +0.63% and a Zacks Rank #3.
Medidata Solutions (NASDAQ:MDSO) , with an Earnings ESP of +12.31% and a Zacks Rank #3.
Biggest Tech Breakthrough in a Generation
Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.
A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft (NASDAQ:MSFT) in the 1990s. Zacks’ just-released special report reveals 7 stocks to watch. The report is only available for a limited time.
Zacks Investment Research
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.